Location
Bellagio
3600 Las Vegas Blvd South
Las Vegas, Nevada
Phone: (702) 693-7111
Grand Ballroom
Faculty
Professor Mike Dixon
Professor of Surgery and Consultant Surgeon
Academic Office
Edinburgh Breast Unit
Western General Hospital
Edinburgh, United Kingdom
Julie R Gralow, MD
Professor, Medical Oncology
University of Washington and Fred Hutchinson Cancer Research Center
Director, Breast Medical Oncology
Seattle Cancer Care Alliance/University of Washington
Seattle, Washington
Clifford Hudis, MD
Chief, Breast Cancer Medicine Service
Solid Tumor Division
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York
Thomas B Julian, MD
Associate Professor, Human Oncology
Drexel University College of Medicine
Associate Director, Breast Care Center
Allegheny Cancer Center, Allegheny General Hospital
Pittsburgh, Pennsylvania
Sandra M Swain, MD
Medical Director, Washington Cancer Institute
Washington Hospital Center
Professor of Medicine, Georgetown University
Washington, DC
Moderator Neil Love, MD
Editor, Breast Cancer Update Audio Series
Research To Practice
Miami, Florida
There is no registration fee for this event. However, preregistration is required. (Not part of the Society’s CME-submitted programming.) In order to participate, you must be registered for the main conference.
Location
Bellagio
3600 Las Vegas Blvd South
Las Vegas, Nevada
Phone: (702) 693-7111
Grand Ballroom
Faculty
Professor Mike Dixon
Professor of Surgery and Consultant Surgeon
Academic Office
Edinburgh Breast Unit
Western General Hospital
Edinburgh, United Kingdom
Julie R Gralow, MD
Professor, Medical Oncology
University of Washington and Fred Hutchinson Cancer Research Center
Director, Breast Medical Oncology
Seattle Cancer Care Alliance/University of Washington
Seattle, Washington
Clifford Hudis, MD
Chief, Breast Cancer Medicine Service
Solid Tumor Division
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York
Thomas B Julian, MD
Associate Professor, Human Oncology
Drexel University College of Medicine
Associate Director, Breast Care Center
Allegheny Cancer Center, Allegheny General Hospital
Pittsburgh, Pennsylvania
Sandra M Swain, MD
Medical Director, Washington Cancer Institute
Washington Hospital Center
Professor of Medicine, Georgetown University
Washington, DC
Moderator Neil Love, MD
Editor, Breast Cancer Update Audio Series
Research To Practice
Miami, Florida
There is no registration fee for this event. However, preregistration is required. (Not part of the Society’s CME-submitted programming.) In order to participate, you must be registered for the main conference.
Target Audience
This activity has been designed to meet the educational needs of general surgeons and surgical oncologists that treat breast cancer.
Learning Objectives and Goals
Apply the results of emerging research in breast cancer clinical management to treatment and referral strategies for patients with early stage disease.
Educate pre- and postmenopausal patients with ER-positive breast cancer about the risks, benefits and duration of adjuvant endocrine therapy.
Recognize the variability in routine ER, PR and HER2 testing and implement appropriate guidelines to maximize accurate pathologic assessment.
Develop a treatment plan for patients with HER2-positive breast cancer considering tumor size and nodal status.
Effectively utilize biomarkers and genomic risk classifiers to estimate patient prognosis and select/recommend adjuvant therapy.
Counsel patients about the value of sentinel lymph node biopsy and its impact on further local and systemic treatment.
Discuss the risks and benefits of partial breast irradiation and the clinical trials evaluating this technique with appropriately selected patients.
Recall the design and eligibility criteria for ongoing breast cancer clinical trials and consent or refer appropriate patients for study participation.
CME Credit Form
A CME credit form will be given to each participant at the conclusion of each activity.
Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Research To Practice designates each educational activity for a maximum of 2 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in each of the activities.
Disclosure Policy
As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Financial disclosures and disclosures of discussions of unlabeled/unapproved uses of drugs or devices will be provided in meeting course materials.
This event is supported by educational grants from Genentech BioOncology and Genomic Health Inc.
For the fourth year in a row, the American Society of Breast Surgeons has elected to partner with our group to host the official satellite symposium at the 11th Annual Meeting. Once again, we have developed an innovative concept that we believe will help create a truly beneficial and worthwhile event.
After several years of focusing on the presentation of clinical data, we will take a different approach and concentrate on the practical application of research findings in cancer management and patient care. To that end, the meeting will not include didactic presentations and rather will rely upon the expert perspectives of clinical investigators commenting on actual early breast cancer cases. Prior to the meeting, we will invite all Society members to submit challenging cases from their own practices for consideration. Our scientific staff in conjunction with the invited faculty will select specific cases for presentation at the meeting by the treating physician.
After each case presentation, we will poll the audience using electronic keypad devices to obtain their treatment recommendations. Members of the interdisciplinary faculty panel will then be called upon to discuss their approach to the case in the context of emerging clinical research and ongoing trials.
We are extremely excited about this event and believe the lively discussion and fascinating perspectives that emerge will provide relevant, practical and important educational information on the management of early breast cancer.
A detailed agenda will be posted in the coming weeks.
There is no registration fee for this event. However, preregistration is required. (Not part of the Society’s CME-submitted programming.) In order to participate, you must be registered for the main conference.
Location
Bellagio
3600 Las Vegas Blvd South
Las Vegas, Nevada
